Streetbeat News

Price Targets

IMVT

HC Wainwright & Co. has maintained its Buy rating for Immunovant (NASDAQ:IMVT) and raised its price target from $26.00 to $27.00. Shares of Immunovant are currently trading down 3.77% at $22.86 per share.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:04 pm

RBT

Canaccord Genuity has maintained its Buy rating for Rubicon Technologies (NYSE:RBT) but lowered its price target from $4.00 to $3.00. Rubicon Technologies' shares are currently trading down 13.04% at $0.60 per share.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:03 pm

ZM

Evercore ISI Group maintains its In-Line rating for Zoom Video Comms (NASDAQ:ZM) and lowers its price target from $85.00 to $75.00. Zoom's shares are trading down 7.71% at $65.90 per share.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:02 pm

GHL

Keefe, Bruyette & Woods upgraded its rating of Greenhill & Co (NYSE:GHL) to Market Perform with a price target of $15.00, up from $6.50. Greenhill & Co shares are trading at $14.69, up 0.17% over the last 24 hours.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:01 pm

EVLV

Cantor Fitzgerald has maintained its Overweight rating for Evolv Technologies (NASDAQ:EVLV) and raised its price target from $6.20 to $7.10. Evolv Technologies' shares are currently trading down 5.55% at $5.62 per share.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:00 pm

GLBE

B of A Securities maintains its Buy rating for Global E Online (NASDAQ:GLBE) and raises its price target from $36.00 to $42.00. Shares of GLBE are trading down 5.81% at $32.91 per share.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:00 pm

BLD

B of A Securities analyst Rafe Jadrosich initiates coverage on TopBuild (NYSE:BLD) with a Buy rating and announces a price target of $255.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 4:57 pm

AMD

AMD shares are trading higher after Bank of America Securities raised its price target on the stock from $105 to $120.

Portfolio Pulse from Bill Haddad

May 23, 2023 | 4:35 pm

CVS

A whale has taken a bearish stance on CVS Health (NYSE:CVS) with 90% of detected unusual options activity being bearish. Whales have been targeting a price range of $62.5 to $75.0 for CVS Health over the last 3 months. Analysts maintain Buy and Outperform ratings with price targets ranging from $88 to $102.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 4:16 pm

RCKT

Needham analyst Gil Blum reiterates a Buy rating on Rocket Pharmaceuticals (NASDAQ:RCKT) and maintains a $60 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 4:10 pm